Two HITLAB Innovators
Featured in Forbes

HITLAB is pleased to announce that two of our innovators have been showcased in Forbes for their continued vision to create a better and healthier every day for every woman around the globe.

New York, NY, March 21, 2022 — HITLAB is pleased to announce that two of our innovators have been showcased in Forbes for their continued vision to create a better and healthier every day for every woman around the globe.

Featured in the article are seven female leaders changing the narrative around inclusivity and accessibility of the healthcare industry, from supporting LGBTQ+ communities and neurodiverse patients to women who have experienced pregnancy loss or abortion, to patients suffering from hormonal imbalance. 

"I wanted to build a company that authentically engages local communities, women, and girls living in the most challenging settings in the world to build quality digital solutions to address the most stigmatized sexual and reproductive health issues."

“Our primary customers are females who are 18-35 years old, single and either in the university or post-secondary school, women who have just started their first job, and married women who have just had their first or second child.”

About HITLAB

Established in 1998, HITLAB is a leading evidence-based, digital health efficacy teaching and testing center specializing in the delivery of world-class digital health innovation research. We help leading organizations ideate, create, and evaluate technology-based solutions to pressing healthcare challenges across the globe. HITLAB works with a wide variety of stakeholders in both the public and private sectors to design and disseminate studies, programs, and products that improve healthcare access and delivery. 

Explore Recent Posts

Rare Disease Day: Technology as a Lifeline for Research

Rare diseases affect millions globally, yet their small patient populations present enormous challenges for research. Recruiting participants for clinical trials can feel impossible, delaying progress and limiting options for those living with these conditions.